Physician profile
Michael D Brown
NPI 1932321155
$7,862.31
in general payments reported to CMS, 2019-2025
32 companies · $1,308 in 2025
The $1,308 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,466 · 2020: $940 · 2021: $1,027 · 2022: $1,171 · 2023: $949 · 2024: $1,002 · 2025: $1,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,162 · Education: $97.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,161.79 |
| Education | $97.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,670.33 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Viiv Healthcare Company | $1,214.31 | 2021-2025 | Apretude, Cabenuva, Dovato |
| Astrazeneca Pharmaceuticals Lp | $956.95 | 2019-2025 | Airsupra, Tezspire |
| Mylan Specialty L.P. | $567.11 | 2019-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $500.49 | 2019-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $353.21 | 2019-2025 | Dupixent |
| Genzyme Corporation | $216.71 | 2021-2025 | |
| Intuitive Surgical, INC. | $213.03 | 2022 | |
| Insmed, INC. | $201.26 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $106.60 | 2020-2025 | Prolastin-C Liquid |
| Medtronic, INC. | $98.74 | 2023-2025 | Illumisite |
| Philips North America LLC | $93.84 | 2019-2025 | (8874) Incourage, (Ak6) Vest Therapy, Vest Therapy Und |
| Novartis Pharmaceuticals Corporation | $90.88 | 2019-2021 | |
| Pfizer INC. | $78.82 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $62.66 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $50.04 | 2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $47.13 | 2020-2022 | |
| Fisher & Paykel Healthcare INC | $38.20 | 2019-2020 | |
| Baxter Healthcare | $31.75 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Ani Pharmaceuticals, INC. | $31.74 | 2025 | Purified Cortrophin Gel |
| Veran Medical Technologies, INC. | $31.14 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.93 | 2023-2024 | Lifevest |
| Portola Pharmaceuticals, LLC | $24.83 | 2020 | |
| United Therapeutics Corporation | $22.21 | 2021-2024 | Remodulin, Orenitram |
| Pentax of America, INC. | $22.02 | 2024 | Pentax Medical, Inspira, C2 Cryoballoon |
| Genentech USA, INC. | $21.80 | 2019 | |
| Lilly USA, LLC | $17.86 | 2025 | Zepbound |
| Amgen INC. | $16.13 | 2022 | |
| Viatris Specialty LLC | $16.02 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $13.87 | 2025 | Inspire |
| Allergan, INC. | $12.56 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.